Aortic complications of giant cell arteritis: a diagnostic and management dilemma.
We describe three giant cell aortitis patients who were operatively managed at our institution over the last seven years and review the recent relevant literature to highlight the specific features of the disease and the salient points of management in relation to the cardiac surgeon.
Butler
Nick
N
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia. nickbutler@doctors.org.uk
Mundy
Julie
J
Shah
Pallav
P
D000368:Aged; D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D000792:Angiography / Q000379:methods; D017545:Aortic Aneurysm, Thoracic / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D001022:Aortic Valve Insufficiency / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D001025:Aortitis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D004638:Emergency Treatment; D005260:Female; D005500:Follow-Up Studies; D013700:Giant Cell Arteritis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D019918:Heart Valve Prosthesis Implantation / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011239:Prednisolone / Q000627:therapeutic use; D012086:Reoperation; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors
D011239:Prednisolone